文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

危重急性肾损伤患者启动肾脏替代治疗的时间:STARRT-AKI 试验的二次分析

Time to Renal Replacement Therapy Initiation in Critically Ill Patients With Acute Kidney Injury: A Secondary Analysis of the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial.
PubMed 文献 · Crit Care Med · 2025-03-03
一句话结论STARRT-AKI 试验标准策略组中,无紧急指征的严重 AKI 患者延迟启动 RRT 与 90 天死亡风险升高无关。

该研究为 STandard vs. Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury(STARRT-AKI)试验的事后二次分析,纳入标准策略组 1462 例患者,其中 903 例(62%)接受了 RRT。暴露为随机化至 RRT 启动的时间,按四分位数及连续变量分析。主要终点 90 天全因死亡:与第 1 四分位相比,第 4 四分位调整比值比 0.63(95%CI 0.42-0.94);但采用立方样条和逆概率加权处理不死时间偏倚后,未显示与死亡风险的关联。RRT 启动时间与 90 天无 RRT 天数、无住院天数、ICU 或住院时长无关联;较长延迟与 90 天 RRT 依赖呈线性关联。

要点

  • 在 STARRT-AKI 标准策略组接受 RRT 的 903 例患者中,RRT 启动时间中位数(四分位距)第 1-4 四分位分别为 12.1(8.3-13.8)小时、24.5(21.8-26.5)小时、46.8(35.2-52.1)小时、96.1(76.7-139.2)小时。
  • 第 4 四分位 vs 第 1 四分位 90 天死亡调整比值比 0.63(95%CI 0.42-0.94);采用立方样条和逆概率加权后,未显示与死亡风险的关联。
  • RRT 启动时间与 90 天无 RRT 天数、无住院天数、ICU 或住院时长均无关联。
  • 较长延迟与 90 天 RRT 依赖呈线性关联。
  • 作者结论:在无紧急指征且接受 RRT 的标准策略患者中,较长延迟启动 RRT 与死亡风险升高无关。

适用人群与场景

  • STARRT-AKI 试验中分配至标准策略组、缺乏 RRT 紧急指征的危重严重急性肾损伤患者。
  • 分析限于标准策略组中实际接受 RRT 的 903 例(占该组 1462 例的 62%)。

研究设计与关键结果

  • 研究设计:STARRT-AKI 多国试验的事后二次分析;暴露为随机化至 RRT 启动的时间,按四分位数和连续变量评估。
  • 人群与样本量:标准策略组 1462 例中 903 例(62%)接受 RRT;RRT 启动时间中位数(四分位距)第 1-4 四分位分别为 12.1(8.3-13.8)小时、24.5(21.8-26.5)小时、46.8(35.2-52.1)小时、96.1(76.7-139.2)小时。
  • 主要终点:90 天全因死亡,第 4 四分位 vs 第 1 四分位调整比值比 0.63(95%CI 0.42-0.94);采用立方样条和逆概率加权处理不死时间偏倚后,未显示与死亡风险的关联。
  • 次要终点:RRT 启动时间与 90 天无 RRT 天数、无住院天数、ICU 或住院时长无关联;较长延迟与 90 天 RRT 依赖呈线性关联。

证据类型、等级与局限

  • 证据类型:多国随机对照试验的事后二次分析。
  • 局限:事后二次分析;采用立方样条和逆概率加权处理不死时间偏倚后,死亡关联不再显著。

对床旁实践的改变

  • 对于无紧急指征的危重严重 AKI 患者,在标准策略下接受 RRT 者,较长延迟启动 RRT 与 90 天死亡风险升高无关。
  • 延迟启动 RRT 与 90 天 RRT 依赖呈线性关联。

指南或共识出处

  • STARRT-AKI 试验(STandard vs. Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Among critically ill patients with severe acute kidney injury (AKI) who lack emergent indications for renal replacement therapy (RRT), a strategy of preemptive RRT initiation does not lead to improved outcomes. However, for patients with persistent AKI and without urgent indications for RRT, the safety of prolonged delays in RRT initiation is unclear. We sought to assess the association between progressively longer delays in RRT initiation and clinical outcomes.

DESIGN: A post hoc secondary analysis.

SETTING: The multinational STandard vs. Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial.

PATIENTS: Participants allocated to the standard strategy of the STARRT-AKI trial.

INTERVENTIONS: The exposure was time from randomization to RRT initiation, evaluated in quartiles and as a continuous variable.

MEASUREMENTS AND MAIN RESULTS: The primary outcome was all-cause mortality at 90 days. Secondary outcomes were RRT dependence, RRT-free days, and hospital-free days, all at 90 days, as well length of ICU and hospital stay. Of the 1462 participants allocated to the standard strategy group, 903 (62%) received RRT. Median time (interquartile range) to RRT initiation was 12.1 hours (8.3-13.8 hr), 24.5 hours (21.8-26.5 hr), 46.8 hours (35.2-52.1 hr), and 96.1 hours (76.7-139.2 hr) in quartiles 1-4, respectively. Prolonged time to RRT initiation was associated with a lower risk of death at 90 days (quartile 4 vs. 1: adjusted odds ratio, 0.63 [95% CI, 0.42-0.94]); further analyses using cubic splines and inverse probability weighting to account for immortal time bias showed no association with the risk of death. There was no association between time to RRT initiation and RRT-free days, hospital-free days, or lengths of ICU or hospital stay. Longer delay to RRT initiation had a linear association with RRT dependence at 90 days.

CONCLUSIONS: Among patients with no urgent indications and who received RRT in the standard strategy of the STARRT-AKI trial, longer deferral of RRT initiation was not associated with a higher risk of mortality.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Jeong R, Bagshaw SM, Ghamarian E, et al. Time to Renal Replacement Therapy Initiation in Critically Ill Patients With Acute Kidney Injury: A Secondary Analysis of the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial. Crit Care Med. 2025. PMID: 40029115. doi:10.1097/CCM.0000000000006616

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。